Table 1.
Patients’ clinical characteristics.
| Homologous Vaccine Scheme (n = 25) |
Heterologous Vaccine Scheme (n = 84) |
p Value | |
|---|---|---|---|
| Median Age (range) | 52 (10) | 58 (13) | 0.051 |
| Sex (%) Female Male |
12 (48) 13 (52) |
45 (53) 39 (45) |
0.147 |
| Comorbidities (%) Hypertension Diabetes Mellitus Asthma/COPD Chronic Liver disease |
5 (20) 1 (4) 0 0 |
30 (36) 19 (22) 4 (5) 3 (4) |
0.22 0.04 0.57 1.00 |
| Diagnoses (%) Colorectal Cancer Breast Cancer Gastric Cancer Other solid tumors |
13 (52) 4 (16) 2 (8) 6 (24) |
42 (50) 13 (15) 9 (10) 20 (24) |
0.457 |
| Stage Localized Metastatic |
8 (32) 17 (68) |
29 (35) 55 (65) |
0.815 |
| Median Lymphocyte blood count (IQR) | 1260 (1005 –1855) |
1410 (1020 –1910) |
0.69 |
| Chemotherapy before first COVID19 vaccination Yes No |
9 (36) 16 (64) |
32 (38) 52 (62) |
0.849 |